The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Omesar 40 mg film-coated tablets

40 milligram(s) Film-coated tablet

LTT Pharma LimitedPPA1562/140/002

Main Information

Trade NameOmesar 40 mg film-coated tablets
Active SubstancesOlmesartan medoxomil
Strength40 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderLTT Pharma Limited
Licence NumberPPA1562/140/002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain


Withdrawn Date17/02/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0865/011/003.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0105-004-003
Interchangeable List DocumentPDF of Interchangeable List
« Back